← Leaderboards
Mohab M Ibrahim
Southern Arizona Va Health Care System
$3,046,125
Attributed
$3,599,135
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,599,135 · 3
VA$0 · 1
By mechanism
R01$2,102,015 · 1
UG3$1,106,020 · 1
R21$391,100 · 1
I01$0 · 1
Top collaborators
- Braxton Norwood1 shared
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationChronic PainReportingClinical TrialsPain ManagementPainOpioidInflammatoryPlasmaPharmaceutical PreparationsExperimental StudyCytokineAnalgesicsCostPain ReductionSafetyPainful NeuropathySide EffectClinicChronic Painful ConditionAreaMechanicsMigraineHypersensitivity
Grant awards (11)
Identifying the Role of the Periaqueductal Gray in Mediating Traumatic Brain Injury Induced Thermal and Mechanical Hypersensitivity Reduction After Green Light Exposure$0
I01 · FY2025 · VA · contact PI
Identifying the Role of the Periaqueductal Gray in Mediating Traumatic Brain Injury Induced Thermal and Mechanical Hypersensitivity Reduction After Green Light Exposure$0
I01 · FY2024 · VA · contact PI
Developing Radiocaine NaV imaging as a response monitoring biomarker for chronic pain$1,106,020
UG3 · FY2023 · NS
Green Light Therapy for Chronic Pain$345,375
R01 · FY2022 · AT · contact PI
Repurposing Sulfasalazine in a Two-Arm Phase Two Double-Blind Randomized Clinical Trial for the Adjunct Management of Breast Cancer-Induced Bone Pain$175,816
R21 · FY2022 · CA · contact PI
Green Light Therapy for Chronic Pain$345,375
R01 · FY2021 · AT · contact PI
Repurposing Sulfasalazine in a Two-Arm Phase Two Double-Blind Randomized Clinical Trial for the Adjunct Management of Breast Cancer-Induced Bone Pain$215,284
R21 · FY2021 · CA · contact PI
Green Light Therapy for Chronic Pain$375,140
R01 · FY2020 · AT · contact PI
Green Light Therapy for Chronic Pain$345,375
R01 · FY2020 · AT · contact PI
Green Light Therapy for Chronic Pain$345,375
R01 · FY2019 · AT · contact PI
Green Light Therapy for Chronic Pain$345,375
R01 · FY2018 · AT · contact PI